Sentinel node biopsy using a magnetic tracer versus standard technique: The SentiMAG multicentre trial

Annals of Surgical Oncology

Volumn 21, Issue 4, 2014, Pages 1237-1245

  Douek, Michael ^a,b   Klaase, Joost ^c   Monypenny, Ian ^d   Kothari, Ashutosh ^b   Zechmeister, Katalin ^e   Brown, Douglas ^f   Wyld, Lynda ^g   Drew, Philip ^h   Garmo, Hans ^a   Agbaje, Olorunsola ^a   Pankhurst, Quentin ⁱ   Anninga, Bauke ^a,j   Grootendorst, Maarten ^a,j   Ten Haken, Bennie ^j   Hall Craggs, Margaret A ^k   Purushotham, Arnie ^a,b   Pinder, Sarah ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

^d UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^e NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^f UNIVERSITY OF DUNDEE   (United Kingdom)

^g UNIVERSITY OF SHEFFIELD   (United Kingdom)

^h ROYAL CORNWALL HOSPITALS NHS TRUST   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j UNIVERSITY OF TWENTE   (Netherlands)

^k UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE; TRACER;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; SENTINEL LYMPH NODE BIOPSY; TUMOR CELL; UNITED KINGDOM; YOUNG ADULT;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COLORING AGENTS; FALSE NEGATIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL AGENCIES; LYMPH NODES; MAGNETIC PHENOMENA; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 84896076179     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3379-6     Document Type: Article

References (24)

1. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456-66. (Pubitemid 8063506)
2. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst. 2006;98:599-609. (Pubitemid 43904843)
3. Cody HS III, Fey J, Akhurst T, et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol. 2001;8:13-9. (Pubitemid 32126820)
4. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703-20. (Pubitemid 46291835)
5. Straver ME, Meijnen P, van Tienhoven G, et al. Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol. 2010;17:1854-61.
6. Goyal A, Newcombe RG, Chhabra A, Mansel RE. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer: results of the ALMANAC validation phase. Breast Cancer Res Treat. 2006;99:203-8. (Pubitemid 44268268)
7. White V, Harvey JR, Griffith CD, Youssef M, Carr M. Sentinel lymph node biopsy in early breast cancer surgery: working with the risks of vital blue dye to reap the benefits. Eur J Surg Oncol. 2011;37:101-8.
8. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-8; discussion 398-401.
9. Joshi T, Pankhurst QA, Hattersley S, et al. Magnetic nanoparticles for detecting cancer spread. Breast Cancer Res Treat. 2007;1006(Suppl. 1):S129.
10. Johnson L, Douek M. Magnetic sentinel lymph node detection for breast cancer. Cancer Res. 2010;70:140s.
11. Gunasekera UA, Pankhurst QA, Douek M. Imaging applications of nanotechnology in cancer. Target Oncol. 2009;4:169-81.
12. Johnson L, Gunasekera A, Douek M. Applications of nanotechnology in cancer. Discov Med. 2010;9:374-9.
13. Johnson L, Pinder SE, Douek M. Deposition of superparamagnetic iron-oxide nanoparticles in axillary sentinel lymph nodes following subcutaneous injection. Histopathology. 2013;62:481-6.
14. Motomura K, Ishitobi M, Komoike Y, et al. SPIO-enhanced magnetic resonance imaging for the detection of metastases in sentinel nodes localized by computed tomography lymphography in patients with breast cancer. Ann Surg Oncol. 2011;18:3422-9.
15. Cserni G, Bianchi S, Boecker W, et al. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer. 2005;103:358-67. (Pubitemid 40129296)
16. Newcombe RG. Improved confidence intervals for the difference between binomial proportions based on paired data. Stat Med. 1998;17:2635-50. (Pubitemid 28510655)
17. Wishart GC, Loh SW, Jones L, Benson JR. A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer. Eur J Surg Oncol. 2012;38:651-6.
18. Motomura K, Inaji H, Komoike Y, Kasugai T, Noguchi S, Koyama H. Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. Jpn J Clin Oncol. 1999;29:604-7.
19. Takeuchi M, Sugie T, Abdelazeem K, et al. Lymphatic mapping with fluorescence navigation using indocyanine green and axillary surgery in patients with primary breast cancer. Breast J. 2012;18:535-41.
20. Sugie T, Sawada T, Tagaya N, et al. Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer. Ann Surg Oncol. 2013;20:2213-8.
21. Abe H, Mori T, Umeda T, et al. Indocyanine green fluorescence imaging system for sentinel lymph node biopsies in early breast cancer patients. Surg Today. 2011;41:197-202.
22. Hojo T, Nagao T, Kikuyama M, Akashi S, Kinoshita T. Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer. Breast. 2010;19:210-3.
23. Troyan SL, Kianzad V, Gibbs-Strauss SL, et al. The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol. 2009;16:2943-52.
24. van der Vorst JR, Schaafsma BE, Verbeek FP, et al. Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients. Ann Surg Oncol. 2012;19:4104-11.